Farrero M - Search Results

1

Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.

Castel MA, Farrero M, Vallejos I, Cardona M, Regueiro A, Pérez-Villa F. Castel MA, et al. Among authors: farrero m. Transplant Proc. 2011 Jul-Aug;43(6):2244-6. doi: 10.1016/j.transproceed.2011.06.054. Transplant Proc. 2011. PMID: 21839245

2

Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.

Perez-Villa F, Farrero M, Sionis A, Castel A, Roig E. Perez-Villa F, et al. Among authors: farrero m. J Heart Lung Transplant. 2010 Jul;29(7):817-8. doi: 10.1016/j.healun.2010.02.004. Epub 2010 Apr 2. J Heart Lung Transplant. 2010. PMID: 20363156 Clinical Trial. No abstract available.

3

Bosentan in heart transplantation candidates with severe pulmonary hypertension: efficacy, safety and outcome after transplantation.

Perez-Villa F, Farrero M, Cardona M, Castel MA, Tatjer I, Penela D, Vallejos I. Perez-Villa F, et al. Among authors: farrero m. Clin Transplant. 2013 Jan-Feb;27(1):25-31. doi: 10.1111/j.1399-0012.2012.01689.x. Epub 2012 Aug 2. Clin Transplant. 2013. PMID: 22861120

4

[Association of everolimus with tacrolimus during the first year after heart transplantation: initial experience].

Cardona M, Castel MÁ, Farrero M, Pérez-Villa F. Cardona M, et al. Among authors: farrero m. Med Clin (Barc). 2013 Jul 21;141(2):87-8. doi: 10.1016/j.medcli.2012.12.003. Epub 2013 Feb 4. Med Clin (Barc). 2013. PMID: 23384432 Spanish. No abstract available.

5

Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation.

González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, Lopez-Granados A, Escribano P, Farrero M. González-Vílchez F, et al. Among authors: farrero m. Clin Transplant. 2013 Nov-Dec;27(6):E649-58. doi: 10.1111/ctr.12241. Epub 2013 Sep 12. Clin Transplant. 2013. PMID: 24025040

6

Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?

Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Gonzalez-Vilchez F, et al. Among authors: farrero m. Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23. Int J Cardiol. 2014. PMID: 24309084

7

AXL receptor tyrosine kinase is increased in patients with heart failure.

Batlle M, Recarte-Pelz P, Roig E, Castel MA, Cardona M, Farrero M, Ortiz JT, Campos B, Pulgarín MJ, Ramírez J, Pérez-Villa F, García de Frutos P. Batlle M, et al. Among authors: farrero m. Int J Cardiol. 2014 May 15;173(3):402-9. doi: 10.1016/j.ijcard.2014.03.016. Epub 2014 Mar 15. Int J Cardiol. 2014. PMID: 24681018 Free article.

8

Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.

Farrero M, Blanco I, Batlle M, Santiago E, Cardona M, Vidal B, Castel MA, Sitges M, Barbera JA, Perez-Villa F. Farrero M, et al. Circ Heart Fail. 2014 Sep;7(5):791-8. doi: 10.1161/CIRCHEARTFAILURE.113.000942. Epub 2014 Jul 21. Circ Heart Fail. 2014. PMID: 25047042

9

Levosimendan as an adjunctive therapy to MitraClip implantation in patients with severe mitral regurgitation and left ventricular dysfunction.

Freixa X, Hernández M, Farrero M, Sitges M, Jiménez G, Regueiro A, Fita G, Tatjer I, Andrea R, Martín-Yuste V, Brugaletta S, Masotti M, Sabaté M. Freixa X, et al. Among authors: farrero m. Int J Cardiol. 2016 Jan 1;202:517-8. doi: 10.1016/j.ijcard.2015.09.056. Epub 2015 Sep 25. Int J Cardiol. 2016. PMID: 26440466 No abstract available.

10

Cost-Effectiveness of Highly Sensitive Cardiac Troponin T to Rule Out Acute Rejection After Heart Transplantation.

Méndez AB, Ordonez-Llanos J, Farrero M, Mirabet S, Brossa V, López L, Bonet R, Sionis A, Pérez-Villa F, Roig E. Méndez AB, et al. Among authors: farrero m. Transplant Proc. 2015 Oct;47(8):2395-6. doi: 10.1016/j.transproceed.2015.08.039. Transplant Proc. 2015. PMID: 26518938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters